[On intraperitoneal administration of sodium cephalothin (Keflin "Shionogi"). On safety of administration under anesthesia].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000768:Anesthesia, General; D002512:Cephalothin / Q000008:administration & dosage / Q000009:adverse effects*; D013505:Digestive System Surgical Procedures; D004347:Drug Interactions; D005260:Female; D005767:Gastrointestinal Diseases / Q000601:surgery; D005831:Genital Diseases, Female / Q000601:surgery; D006801:Humans; D007274:Injections, Intraperitoneal; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D007744:Obstetric Labor Complications / Q000601:surgery; D011247:Pregnancy; D012119:Respiration / Q000187:drug effects; D013530:Surgical Wound Infection / Q000517:prevention & control
D009125:Muscle Relaxants, Central; D002512:Cephalothin